Global Cancer Diagnostics Market Was Worth US$ 18.41 Billion in 2022, Estimated to Gain CAGR of 12.0% During 2023-2031.

Cancer diagnostics involves identifying and determining the presence, type, and stage of cancer in a patient’s body. It employs various techniques such as imaging, biopsies, and blood tests to detect abnormalities at cellular and molecular levels. Accurate diagnostics are crucial for effective treatment planning and monitoring the progression of the disease.

Consumables are dominating the global cancer diagnostics market within the product category. The consistent demand for reagents, antibodies, and test kits contributes to their dominance. A study published in the journal “Cancer Epidemiology, Biomarkers & Prevention” highlighted the substantial usage of consumables in cancer screening, diagnosis, and monitoring, solidifying their dominant market position.

Global Cancer Diagnostics Market Revenue & Forecast, (US$ Million), 2015 – 2031

COVID-19 Impact Analysis on Global Cancer Diagnostics Market

Before the pandemic, the cancer diagnostics market was on a trajectory of steady growth. Innovations in imaging technologies and molecular diagnostics were enhancing early detection and precision treatments, fostering market expansion. The COVID-19 pandemic brought significant shifts to the cancer diagnostics market. Delayed screenings and disrupted healthcare services impacted diagnosis rates. However, the crisis highlighted the importance of resilient diagnostics. Telemedicine adoption and advancements in at-home testing gained prominence, influencing the market’s direction towards more adaptable and patient-centric solutions.

A key driver in the cancer diagnostics market is the growing emphasis on early detection. The American Cancer Society reported that early diagnosis improves survival rates and treatment outcomes. Innovations like liquid biopsies offer non-invasive methods for detecting cancer-associated biomarkers. A study published in “Cancer Epidemiology, Biomarkers & Prevention” highlighted the potential of such approaches. This driver reflects the industry’s commitment to enhancing patient prognosis by detecting cancers at their nascent stages, guiding timely interventions. The substantial costs associated with advanced cancer diagnostic techniques pose a significant restraint. Expensive instruments, specialized training, and complex procedures contribute to the financial burden. A study in the journal “JAMA Oncology” highlighted the economic challenges patients face due to high diagnostic costs. This restraint can hinder access to cutting-edge diagnostics, impacting timely diagnosis and care.

Breast cancer diagnostics is dominating the global cancer diagnostics market within the application category in 2022. Breast cancer accounts for a significant portion of cancer cases, with a substantial focus on early detection. The American Cancer Society notes that mammography screenings have contributed to reduced mortality rates, underscoring the dominance of breast cancer diagnostics.

North America accounted for ~45.8% of the global cancer diagnostics market in 2022. It boasts advanced healthcare infrastructure and proactive screening programs. According to the American Cancer Society, North America has among the highest cancer screening rates globally, indicating its dominant position in diagnostics.

Competitive Landscape

A few of the players operating in the global cancer diagnostics market are

• Abbott
• BD
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd
• GE HealthCare
• Hologic, Inc.
• Koninklijke Philips N.V.
• QIAGEN
• Siemens Healthcare GmbH
• Thermo Fisher Scientific Inc.
• Other Industry Participants

Global Cancer Diagnostics Market Report Coverage

Report Specifications	Details
Market Revenue in 2022	US$ 18.41 Billion
Market Size Forecast by 2031	US$ 51.51 Billion
Growth Rate (CAGR)	12%
Historic Data	2015 – 2021
Base Year for Estimation	2022
Forecast Period	2023 – 2031
Report Inclusions	Market Size & Estimates, Market Dynamics, Competitive Scenario, Trends, Growth Factors, Market Determinants, Key Investment Segmentation, Product/Service/Solutions Benchmarking
Segments Covered	By Product, By Application, By End User
Regions Covered	North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Countries Covered	U.S., Canada, Mexico, Rest of North America,  France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe,  China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific,  Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa,  Brazil, Argentina, Rest of Latin America
Key Players	Abbott, BD, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, GE HealthCare, Hologic, Inc., Koninklijke Philips N.V., QIAGEN, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Other Industry Participants
Customization Scope	Customization allows for the inclusion/modification of content pertaining to geographical regions, countries, and specific market segments.
Pricing & Procurement Options	Explore purchase options tailored to your specific research requirements
Contact Details	Consult With Our Expert Japan (Toll-Free): +81 663-386-8111 South Korea (Toll-Free): +82-808-703-126 Saudi Arabia (Toll-Free): +966 800-850-1643 United Kingdom: +44 753-710-5080 United States: +1 302-232-5106 E-mail:  askanexpert@thenicheresearch.com

 

Global Cancer Diagnostics Market:

By Product

• Consumables

• • Antibodies
  • Kits & Reagents
  • Probes
  • Other Consumables

• Instruments

• • Pathology-Based Instruments
    • Slide Staining Systems
    • Tissue Processing Systems
    • NGS Instruments
    • Cell Processors
    • PCR Instruments
    • Microarrays
    • Other Pathology-Based Instruments
  • Imaging Instruments
    • CT Systems
    • MRI Systems
    • Ultrasound Systems
    • Mammography Systems
    • Nuclear Imaging Systems
  • Biopsy Instruments

By Application

• Breast Cancer
• Colorectal Cancer
• Cervical Cancer
• Lung Cancer
• Prostate Cancer
• Skin Cancer
• Blood Cancer
• Kidney Cancer
• Liver Cancer
• Pancreatic Cancer
• Ovarian Cancer
• Others

By End User

• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Others

By Region

• North America (U.S., Canada, Mexico, Rest of North America)
• Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
• Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
• Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
• Latin America (Brazil, Argentina, Rest of Latin America)

Report Coverage and Deliverables: 

Table of Contents

.

.

**Exclusive for Multi-User and Enterprise User.

Global Cancer Diagnostics Market Segmentation

By Product

By Application

By End User

By Region

**Note: The report covers cross-segmentation analysis by region further into countries

.

The Niche Research approach encompasses both primary and secondary research methods to provide comprehensive insights. While primary research is the cornerstone of our studies, we also incorporate secondary research sources such as company annual reports, premium industry databases, press releases, industry journals, and white papers. Within our primary research, we actively engage with various industry stakeholders, conducting paid interviews and surveys. Our meticulous analysis extends to every market participant in major countries, allowing us to thoroughly examine their portfolios, calculate market shares, and segment revenues. Our data collection primarily focuses on individual countries within our research scope, enabling us to estimate regional market sizes. Typically, we employ a bottom-up approach, meticulously tracking trends in different countries. We analyze growth drivers, constraints, technological innovations, and opportunities for each country, ultimately arriving at regional figures.Our process begins by examining the growth prospects of each country. Building upon these insights, we project growth and trends for the entire region. Finally, we utilize our proprietary model to refine estimations and forecasts. Our data validation standards are integral to ensuring the reliability and accuracy of our research findings. Here's a breakdown of our data validation processes and the stakeholders we engage with during our primary research:

• Supply Side Analysis: We initiate a supply side analysis by directly contacting market participants, through telephonic interviews and questionnaires containing both open-ended and close-ended questions. We gather information on their portfolios, segment revenues, developments, and growth strategies.
• Demand Side Analysis: To gain insights into adoption trends and consumer preferences, we reach out to target customers and users (non-vendors). This information forms a vital part of the qualitative analysis section of our reports, covering market dynamics, adoption trends, consumer behavior, spending patterns, and other related aspects.
• Consultant Insights: We tap into the expertise of our partner consultants from around the world to obtain their unique viewpoints and perspectives. Their insights contribute to a well-rounded understanding of the markets under investigation.
• In-House Validation: To ensure data accuracy and reliability, we conduct cross-validation of data points and information through our in-house team of consultants and utilize advanced data modeling tools for thorough verification.

The forecasts we provide are based on a comprehensive assessment of various factors, including:

• Market Trends and Past Performance (Last Five Years): We accurately analyze market trends and performance data from preceding five years to identify historical patterns and understand the market's evolution.
• Historical Performance and Growth of Market Participants: We assess the historical performance and growth trajectories of key market participants. This analysis provides insights into the competitive landscape and individual company strategies.
• Market Determinants Impact Analysis (Next Eight Years): We conduct a rigorous analysis of the factors that are projected to influence the market over the next eight years. This includes assessing both internal and external determinants that can shape market dynamics.
• Drivers and Challenges for the Forecast Period:Identify the factors expected to drive market growth during the forecast period, as well as the challenges that the industry may face. This analysis aids in deriving an accurate growth rate projection.
• New Acquisitions, Collaborations, or Partnerships: We keep a close watch on any new acquisitions, collaborations, or partnerships within the industry. These developments can have a significant impact on market dynamics and competitiveness.
• Macro and Micro Factors Analysis:A thorough examination of both macro-level factors (e.g., economic trends, regulatory changes) and micro-level factors (e.g., technological advancements, consumer preferences) that may influence the market during the forecast period.
• End-User Sentiment Analysis: To understand the market from the end-user perspective, we conduct sentiment analysis. This involves assessing the sentiment, preferences, and feedback of the end-users, which can provide valuable insights into market trends.
• Perspective of Primary Participants: Insights gathered directly from primary research participants play a crucial role in shaping our forecasts. Their perspectives and experiences provide valuable qualitative data.
• Year-on-Year Growth Trend: We utilize a year-on-year growth trend based on historical market growth and expected future trends. This helps in formulating our growth projections, aligning them with the market's historical performance.

Research process adopted by TNR involves multiple stages, including data collection, validation, quality checks, and presentation. It's crucial that the data and information we provide add value to your existing market understanding and expertise. We have also established partnerships with business consulting, research, and survey organizations across regions and globally to collaborate on regional analysis and data validation, ensuring the highest level of accuracy and reliability in our reports.